As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
COVID-19 collection
Click here for recent content published in the Journal of Ovarian Research on COVID-19!
Aims and scope
Journal of Ovarian Research is an open access, peer reviewed, online journal that aims to provide a forum for high-quality basic and clinical research on ovarian function, abnormalities, and cancer. The journal focuses on research that provides new insights into ovarian functions as well as prevention and treatment of diseases afflicting the organ.
Topical areas include, but are not restricted to:
- Ovary development, hormone secretion and regulation
- Follicle growth and ovulation
- Infertility and Polycystic ovarian syndrome
- Regulation of pituitary and other biological functions by ovarian hormones
- Ovarian cancer, its prevention, diagnosis and treatment
- Drug development and screening
- Role of stem cells in ovary development and function
New reviewer recruitment
The Journal of Ovarian Research invites you to join our team of reviewers in assessing manuscripts. For consideration, please send your CV to christina.dzikowski@springernature.com.
Articles
-
-
Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome
-
LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome
-
Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors
-
Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism
-
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
-
Possibility of live birth in patients with low serum β-hCG 14 days after blastocyst transfer
-
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective
-
MicroRNAs in ovarian function and disorders
-
The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer
Trending articles
Click here to view which articles were talked about the most in 2021 so far!
Featured article: A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer
Detailed epidemiologic descriptions of large populations of advanced-stage ovarian cancer patients have been lacking to date. This study aimed to describe the patient characteristics, treatment patterns, survival, and incidence rates of health outcomes of interest (HOI) in a large cohort of advanced-stage ovarian cancer patients in the United States (US).
Announcing the launch of In Review
In-Review
Journal of Ovarian Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Journal of Ovarian Research is affiliated with the CROWN initiative, Core Outcomes in Women’s Health. CROWN is an international initiative, led by journal editors, to harmonise outcome reporting in women’s health research. We are coming together to address the widespread, unwarranted variation in reporting of outcomes. CROWN’s main aim is to encourage researchers to report core outcome sets for key conditions in women’s health.
Editors-in-Chief
Sham S Kakar, University of Louisville, USA
Benjamin K Tsang, University of Ottawa, Canada
Annual Journal Metrics
-
Speed
77 days to first decision for reviewed manuscripts only
61 days to first decision for all manuscripts
140 days from submission to acceptance
18 days from acceptance to publication
Citation Impact
2.989 - 2-year Impact Factor
2.909 - 5-year Impact Factor
1.004 - Source Normalized Impact per Paper (SNIP)
0.927 - SCImago Journal Rank (SJR)
Usage
511,811 Downloads
141 Altmetric mentions